Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Merck
Fish and Richardson
Daiichi Sankyo
Federal Trade Commission
Colorcon
Cerilliant
US Department of Justice

Generated: July 17, 2018

DrugPatentWatch Database Preview

Vernalis R And D Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for VERNALIS R AND D LTD, and when can generic versions of VERNALIS R AND D LTD drugs launch?

VERNALIS R AND D LTD has one approved drug.

There are six US patents protecting VERNALIS R AND D LTD drugs.

There are thirty-seven patent family members on VERNALIS R AND D LTD drugs in six countries.

Summary for Vernalis R And D Ltd
International Patents:37
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Vernalis R And D Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes 6,669,948 ➤ Sign Up Y Y ➤ Sign Up
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes 8,778,924 ➤ Sign Up Y Y ➤ Sign Up
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes 8,357,394 ➤ Sign Up Y ➤ Sign Up
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes 6,544,555 ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Vernalis R And D Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,157,095 Multiple-delayed release antifungal product, use and formulation thereof ➤ Sign Up
6,667,057 Levofloxacin antibiotic product, use and formulation thereof ➤ Sign Up
6,730,320 Tetracycline antibiotic product, use and formulation thereof ➤ Sign Up
6,541,014 Antiviral product, use and formulation thereof ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Medtronic
Fuji
Moodys
Queensland Health
Argus Health
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.